Brief: Scope Fluidics Says Bacteromic Gets Conditional Decision On Granting Patent For Microfluidic Chip
04/02/2022 14:54
Feb 4 (Reuters) - Scope Fluidics SA SCPP.WA :
* BACTEROMIC GETS CONDITIONAL DECISION ON GRANTING PATENT
FOR
MICROFLUIDIC CHIP FROM EUROPEAN PATENT OFFICE
* ACCORDING TO PROCEDURE CONDITION FOR GRANTING PATENT IS
BACTEROMIC'S APPROVAL OF TEXT OF APPLICATION AS PRESENTED BY
OFFICE AND PAYMENT OF REQUIRED FEES
* IF GRANTED PATENT WILL MEAN THAT BACTEROMIC HAS EXCLUSIVE
RIGHT
TO COMMERCIAL USE OF MEASUREMENT CARDS FOR MICROBIOLOGICAL
DETERMINATIONS
Source text for Eikon: ID:nEM6y1DwLa
Further company coverage: SCPP.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics Extends Deadline For First Milestone Of Hybolic Project To End Of Q3 2026
Brief: Scope Fluidics Says Bacteromic Granted U.S. Patent 'Microfluidic Chip'
Brief: Scope Fluidics Q1 Net Loss At 13.5 Million Zlotys
Brief: Scope Fluidics Unit Bacteromic Starts Collaboration With US Research Center For FDA Registration Trials
Brief: Scope Fluidics FY Net Loss At 46.4 Million Zlotys